tiprankstipranks
Trending News
More News >
Assertio Therapeutics Inc (ASRT)
NASDAQ:ASRT

Assertio Therapeutics (ASRT) Revenue

Compare
1,116 Followers

Assertio Therapeutics Revenue

Assertio Therapeutics had a revenue of 32.18M in the quarter ending Dec 31, 2024, with 10.20%. This bring the company's revenue in the last twelve months to 124.96M, Increased -0.64%. In the fiscal year ending Dec 31, 2024, Assertio Therapeutics had annual revenue of 124.96M with -17.83% growth.
Revenue (ttm)
124.96M
Revenue Growth
-16.23%
P/S Ratio
0.47
Revenue/Employee
$2,154,500
Employees
58
Market Cap
$58.94M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
124.96M-27.11M-17.83%
Dec 31, 2023
152.07M-4.17M-2.67%
Dec 31, 2022
156.23M45.22M+40.73%
Dec 31, 2021
111.01M4.74M+4.46%
Dec 31, 2020
106.28M-123.23M-53.69%
Dec 31, 2019
229.50M-82.27M-26.39%
Dec 31, 2018
311.77M-68.95M-18.11%
Dec 31, 2017
380.72M-75.17M-16.49%
Dec 31, 2016
455.90M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis